174 related articles for article (PubMed ID: 25456099)
1. The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.
Saremi A; Schwenke DC; Bahn G; Ge L; Emanuele N; Reaven PD;
Metabolism; 2015 Feb; 64(2):218-25. PubMed ID: 25456099
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
[TBL] [Abstract][Full Text] [Related]
3. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
Paty BW
Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.
Roussel R; Steg PG; Mohammedi K; Marre M; Potier L
Diabetes Obes Metab; 2018 Feb; 20(2):238-244. PubMed ID: 28597588
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study.
Persson F; Nyström T; Jørgensen ME; Carstensen B; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Eriksson JW; Norhammar A; Bodegard J; Birkeland KI
Diabetes Obes Metab; 2018 Feb; 20(2):344-351. PubMed ID: 28771923
[TBL] [Abstract][Full Text] [Related]
6. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
Reaven PD; Moritz TE; Schwenke DC; Anderson RJ; Criqui M; Detrano R; Emanuele N; Kayshap M; Marks J; Mudaliar S; Harsha Rao R; Shah JH; Goldman S; Reda DJ; McCarren M; Abraira C; Duckworth W;
Diabetes; 2009 Nov; 58(11):2642-8. PubMed ID: 19651816
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Cardiovascular Disease in Type 1 Diabetes.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group
Diabetes; 2016 May; 65(5):1370-9. PubMed ID: 26895792
[TBL] [Abstract][Full Text] [Related]
9. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
10. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study.
Díez-Espino J; Basterra-Gortari FJ; Salas-Salvadó J; Buil-Cosiales P; Corella D; Schröder H; Estruch R; Ros E; Gómez-Gracia E; Arós F; Fiol M; Lapetra J; Serra-Majem L; Pintó X; Babio N; Quiles L; Fito M; Marti A; Toledo E;
Clin Nutr; 2017 Aug; 36(4):1015-1021. PubMed ID: 27448949
[TBL] [Abstract][Full Text] [Related]
11. Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.
Getaneh A; Light LS; Brillon DJ; Calles Escandón J; Felicetta J; Evans GW; Lopez-Jimenez CR; Cuddihy R; Bigger JT
J Gen Intern Med; 2012 Nov; 27(11):1499-505. PubMed ID: 22744725
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.
Zinman B; Ahrén B; Neubacher D; Patel S; Woerle HJ; Johansen OE
Can J Diabetes; 2016 Feb; 40(1):50-7. PubMed ID: 26474870
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes control on mortality by race in a national cohort of veterans.
Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
[TBL] [Abstract][Full Text] [Related]
14. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease.
Akintoye E; Mahmoud K; Shokr M; Sandio A; Mallikethi-Reddy S; Sheikh M; Adegbala O; Egbe A; Briasoulis A; Afonso L
Clin Cardiol; 2018 Apr; 41(4):502-509. PubMed ID: 29663526
[TBL] [Abstract][Full Text] [Related]
16. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
17. Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis.
Kershaw KN; Osypuk TL; Do DP; De Chavez PJ; Diez Roux AV
Circulation; 2015 Jan; 131(2):141-8. PubMed ID: 25447044
[TBL] [Abstract][Full Text] [Related]
18. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
[TBL] [Abstract][Full Text] [Related]
19. Representation of people of South Asian origin in cardiovascular outcome trials of glucose-lowering therapies in Type 2 diabetes.
Khunti K; Bellary S; Karamat MA; Patel K; Patel V; Jones A; Gray J; Shepherd P; Hanif W;
Diabet Med; 2017 Jan; 34(1):64-68. PubMed ID: 26926478
[TBL] [Abstract][Full Text] [Related]
20. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
Laffin LJ; Bakris GL
Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
